Dr Laura Bienvenu
Research Ethics Advisor
Office of Research Management
10 Scholarly works
1 Projects
HIGHLIGHTS
2025
Journal article
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion
DOI: 10.1093/cvr/cvaf1652025
Journal article
Development of a Safe and Long-Lasting Dual Antiplatelet/Anticoagulant Therapy for Enhanced Thromboprophylaxis and Cardiac Protection
DOI: 10.1016/j.hlc.2025.06.0532024
Journal article
Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injury without bleeding complications
DOI: 10.7150/thno.975172022
Journal article
New Perspectives on Sex Steroid and Mineralocorticoid Receptor Signaling in Cardiac Ischemic Injury
DOI: 10.3389/fphys.2022.8964252022
Journal article
Biofabrication of advanced in vitro 3D models to study ischaemic and doxorubicin-induced myocardial damage
DOI: 10.1088/1758-5090/ac47d82022
Research grants (other domestic)
Immunomodulatory Therapy for Preserving Cardiac Function Following Myocardial Infarction
2020
Journal article
Higher mortality of COVID-19 in males: Sex differences in immune response and cardiovascular comorbidities
DOI: 10.1093/cvr/cvaa284
RECENT SCHOLARLY WORKS
2018
Journal article
Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia
DOI: 10.1038/s41598-018-20703-82016
Journal article
Angiotensin-(1-9): New Promise for Post-Infarct Functional Therapy ∗
DOI: 10.1016/j.jacc.2016.10.0112016
Journal article
Dietary omega-6 fatty acid replacement selectively impairs cardiac functional recovery after ischemia in female (But not male) rats
DOI: 10.1152/ajpheart.00690.20152013
Journal article
Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: A focus on the cardiomyocyte
DOI: 10.1042/CS20130050